Cytek Biosciences shares owned by Vanguard Group
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 6.9M | 3.47 |
| 2025-06-30 | $26M | 7.8M | 3.40 |
| 2025-03-31 | $39M | 9.6M | 4.01 |
| 2024-12-31 | $76M | 12M | 6.49 |
| 2024-09-30 | $65M | 12M | 5.54 |
| 2024-06-30 | $66M | 12M | 5.58 |
| 2024-03-31 | $81M | 12M | 6.71 |
| 2023-12-31 | $108M | 12M | 9.12 |
| 2023-09-30 | $61M | 11M | 5.52 |
| 2023-06-30 | $91M | 11M | 8.54 |
| 2023-03-31 | $73M | 7.9M | 9.19 |
| 2022-12-31 | $79M | 7.8M | 10.21 |
| 2022-06-30 | $67M | 6.3M | 10.73 |
| 2022-03-31 | $69M | 6.4M | 10.78 |
| 2021-09-30 | $26M | 1.2M | 21.41 |